1 Min Read
Nov 10 (Reuters) - Sarepta Therapeutics Inc -
* SAREPTA THERAPEUTICS ANNOUNCES EXERCISE OF INITIAL PURCHASERS’ OPTION TO PURCHASE ADDITIONAL CONVERTIBLE SENIOR NOTES DUE 2024 Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.